hACE2 Protein (ECD)
These products provide hACE2 proteins for SARS-CoV-2 research and development of COVID-19 therapies.
- The description claims that hACE2 is the entry receptor for SARS-CoV-2 infection.
Specifications
- Variant
- Tag-free liquid formulation, Tag-free lyophilized formulation, Avi/His-Tag biotinylatedt, Avi/His-Tag non-biotinylated
- Size
- 100µg, 500µg, 1mg
Variants (11)
- Tag-free liquid formulation / 100µg — 687.00 USD — In stock
- Tag-free liquid formulation / 500µg — 2152.00 USD — In stock
- Tag-free liquid formulation / 1mg — 3013.00 USD — Out of stock
- Tag-free lyophilized formulation / 100µg — 687.00 USD — Out of stock
- Tag-free lyophilized formulation / 500µg — 2152.00 USD — In stock
- Tag-free lyophilized formulation / 1mg — 3013.00 USD — Out of stock
- Avi/His-Tag biotinylatedt / 100µg — 1036.00 USD — In stock
- Avi/His-Tag biotinylatedt / 500µg — 3478.00 USD — In stock
- Avi/His-Tag biotinylatedt / 1mg — 4641.00 USD — Out of stock
- Avi/His-Tag non-biotinylated / 100µg — 687.00 USD — In stock
- Avi/His-Tag non-biotinylated / 1mg — 3013.00 USD — In stock
How AI sees this product
The more complete this product's details, the more confidently AI assistants can understand and recommend it.
83%